$AZTR

Azitra, Inc. (AZTR): Submission of Matters to a Vote of Security Holders

Azitra, Inc. (AZTR) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. false --12-31 0001701478 0001701478 2026-06-15 2026-06-15 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of

Original reporting
Published Jun 16, 2026, 12:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 16, 2026, 12:31 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
$AZTR
Neutral
medium confidence
Mentioned
$AZTR
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$AZTRNeutralMed
01

Why it matters

Key voted items include increasing authorized common shares, authorizing potential reverse stock splits, ratifying the auditor, and approving NYSE American Guide-compliant issuances related to prior securities purchase agreements.

02

Market read

The shareholder vote outcomes can shift expectations for dilution and share-price mechanics (reverse split optionality), which may drive short-term trading volatility.

03

What to watch

Traders may overreact to the authorized-share headline; the actual near-term dilution depends on whether and when the company draws on the securities purchase agreement and converts/exercises instruments.

Relevance 6/10Novelty 6/10Timing: Filed June 16, 2026 (event June 15 reconvened annual meeting)

Background

This is an SEC Form 8-K reporting results of Azitra’s reconvened 2026 annual meeting (initially adjourned June 4, 2026).

Company-level read

Ticker impact

$AZTRNeutralMedium confidence
Context

Azitra reconvened its 2026 annual meeting and stockholders approved a large authorized-share increase and other capital-structure proposals.

Expected impact

Choppy-to-negative bias possible if traders focus on dilution risk; reverse-split authorization may add uncertainty.

Evidence & confidence

The filing discloses shareholder votes approving (1) authorized common shares from 200M to 750M, (2) authorization for one or more reverse stock splits, and (3) NYSE American Guide-compliant issuance approvals tied to a securities purchase agreement—inputs that can change dilution/financing expectations even without immediate pricing details.

Market effects

For small-cap listed issuers, authorized-share increases and reverse-split authorizations can signal readiness for financing/recapitalization, influencing peer sentiment around similar capital structures.

Limited; primarily affects the US-listed micro/small-cap name on NYSE American.

Low; no cross-border deal or macro linkage disclosed.

Counterpoint

The reverse-split authorization and share-authorizations may be procedural to support existing financing terms rather than a fresh, immediate dilution event.

Key entities

  • Azitra, Inc.

    NYSE American-listed company whose stockholders voted on eight proposals, including capital-structure changes.

  • Alumni Capital LP

    Named in securities purchase agreement(s) referenced by the NYSE American Guide-compliant issuance proposals.

  • Grassi & Co., CPAs, P.C.

    Ratified as independent registered public accounting firm for fiscal year ending Dec. 31, 2026.

Related articles

$AZTRMed

Azitra, Inc. Announces Q2 2026 Results and Provides Business Updates

Azitra, Inc. (NYSE American: AZTR) reported Q2 2026 results for the quarter ended June 30, 2026. R&D was $1.4 million, G&A $2.1 million, and net loss $3.3 million. Cash and cash equivalents were $6.7 million. The company cited preclinical ATR-COSF data, continued Phase 1/2 enrollment for ATR-04 EGFR inhibitor-associated rash, and plans to pause ATR-12 enrollment. Topline ATR-04 data is expected in Q4 2026.

$AZTRMed

Azitra, Inc. (AZTR): Results of Operations and Financial Condition

Azitra, Inc. (AZTR) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Azitra, Inc. Announces Q2 2026 Results and Provides Business Updates BRANFORD, Conn. – August 12, 2026 — Azitra, Inc. (“Azitra” or the “Company”) (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for precisio

$NVDAHighAI 9/10

What Nvidia's $150 billion stock buyback means for shareholders and potential investors

Nvidia announced a $150 billion stock buyback, bringing its total repurchase authorization to $235 billion through 2028. The company has aggressively repurchased shares since 2025, with $34 billion in 2025, $40.4 billion in 2026, and $39 billion in the first half of 2027. Nvidia's stock rose on the news, along with the announcement of its Open Agent Safety Platform. According to analysts, the buyback boosts earnings per share and signals confidence in the company's future.